INC Research's Jeff Kueffer Named to PharmaVOICE 100
(Thomson Reuters ONE) -
Senior Vice President, Global Operations Management, honored
for contributions to clinical innovation and process improvement
Raleigh, N.C., Aug. 1, 2013 - INC Research LLC, a therapeutically focused global
clinical research organization (CRO) with a Trusted Process(®) for delivering
reliable results, today announced Jeff Kueffer, Senior Vice President, Global
Operations Management, has been named to the annual PharmaVOICE 100 list of the
most inspiring people in the life-sciences industry. Mr. Kueffer was selected
for his ability to shape the next-generation clinical development methodologies
and tools needed for drug developers to effectively compete in an evolving
landscape, which includes driving the development and evolution of the Company's
proprietary Trusted Process®.
"Jeff has contributed to INC Research's success by boldly challenging convention
in clinical development, keeping our Company at the leading edge of the
industry," said Jamie Macdonald, Chief Executive Officer. "He was ahead of his
time in measuring the impact of processes on trial quality and delivery, and our
proven Trusted Process(®) methodology continues to benefit our customers and the
industry as a whole."
Mr. Kueffer has been driving clinical development improvements since joining INC
Research nearly a decade ago. His distinguished history of leadership in the
U.S. military contributes to his disciplined approach to problem solving-a
hallmark of his success at the Company. He continues to be a driving force
behind INC Research's Trusted Process(®), the proprietary metrics-driven
clinical trial outsourcing methodology, which has underpinned every trial
conducted by INC since 2006. Through development and implementation of this
standardized process, Mr. Kueffer has made it possible to reduce variability in
clinical trials and increase both efficiency and speed. He remains dedicated
to improving INC Research's efficiency in performing clinical trials and is
currently playing a key role in the Company's initiative focused on delivering
clinical innovation to enhance the drug development process.
Featured in the July/August 2013 issue of PharmaVOICE, Mr. Kueffer was selected
from a group of nominations submitted by industry peers. A panel of PharmaVOICE
editors evaluated the submissions based on nominees' ability to inspire,
motivate and influence corporate leadership, research and development,
technology, creativity, marketing, and strategy. Mr. Kueffer's profile is
featured in the "Change Agents" section of the special issue, a section
dedicated to innovators who are improving clinical development.
About INC Research
INC Research is a therapeutically focused clinical research organization with a
high-performance reputation for conducting global clinical development
programs of the highest integrity. Pharmaceutical and biotechnology companies
look to us for a complete range of customized Phase I to IV programs in
all therapeutic areas and patient populations. Our Trusted Process® methodology
and therapeutic foresight lead customers to better-informed product development
decisions, while our solid site relationships are a critical success factor in
delivering clinical trial results on time and on budget. INC was ranked "Top
CRO" by sites worldwide in the 2013 CenterWatch Global Investigative Site
Relationship Survey. INC Research is headquartered in Raleigh, NC. For more
information, please visit www.incresearch.com or follow us at (at)inc_research.
Contact: Lori Dorer, Media +1 (513) 345-1685
This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: INC RESEARCH, LLC via Thomson Reuters ONE
[HUG#1720701]
Unternehmensinformation / Kurzprofil:
Bereitgestellt von Benutzer: hugin
" alt="Exeter Resource Corporation: Unusual Trading ActivityDatum: 01.08.2013 - 18:10 Uhr
Sprache: Deutsch
News-ID 284082
Anzahl Zeichen: 4450
contact information:
Town:
Raleigh
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 305 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"INC Research's Jeff Kueffer Named to PharmaVOICE 100"
steht unter der journalistisch-redaktionellen Verantwortung von
INC RESEARCH, LLC (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
